erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the. march 2011 (20).. https://oakley-sunglassesformen.us/Belile-daughter-of-Courtwright-from-Earnscleugh?Kneemothe=133 schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.". share on google plus google-plus ..